Key Record Dates
ClinicalTrials.gov Identifier: | NCT04337359 |
---|---|
Brief Title: | Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness |
First Submitted : | April 3, 2020 |
First Submitted that Met QC Criteria : | April 3, 2020 |
First Posted : | April 7, 2020 |
Last Update Submitted that Met QC Criteria : | July 7, 2020 |
Last Update Posted : | July 9, 2020 |